Stanford
http://www.stanfordgroup.com/#Stanford provides institutional investment services and private wealth management services. The firm also offers equity research to its clients in the consumer, media, energy, financial, healthcare, technology and water/environment sectors.
View Older Stories View More Recent Stories
-
Insulet (PODD) Announces CEO Transition
-
Smart for Life (SMFL) Appoints Darren C. Minton as CEO
-
Stanford University given $1.1 billion by venture capitalist for climate change school
-
Esports Entertainment Group (GMBL) Appoints Jan Jones Blackhurst to its Board
-
CSS Entertainment's (CSSE) Cracke Announces New Originals, Exclusives, Movies, and Series for May
-
E2open (ETWO) Names Marje Armstrong as New Chief Financial Officer
-
Jasper Therapeutics (JSPR) Reports Updated Data from Phase 1 Clinical Trial of JSP191
-
First patients ‘filter free’ after laser-assisted Inferior Vena Cava (IVC) filter removal with Philips CavaClear
-
First patients ‘filter free’ after laser-assisted Inferior Vena Cava (IVC) filter removal with Philips CavaClear
-
Pixelworks (PXLW) Appoints Dean Butler to its Board
-
eBay (EBAY) Names Eddie Garcia Chief Product Officer
-
Cadre Holdings (CDRE) Appoints Deborah DeCotis to its Board
-
Smith Micro Software (SMSI) Appoints New Members to the Board of Directors
-
Cytokinetics (CYTK) Announces Changes to Board of Directors
-
Stanford Federal Credit Union Eliminates Non-Sufficient Funds Fees for its Members
-
Stanford Federal Credit Union Selects Empower, Black Knight's Loan Origination System, and Integrated Solutions to Automate and Elevate the Member Experience
-
FSD Pharma Inc. (HUGE) Issues Corporate Updates
-
Natera (NTRA) Announces Appointments to Organ Health Medical Affairs Leadership Team
-
Cepton, Inc. (CPTN) Announces Chief Financial Officer Transition
-
Hasbro (HAS) Announces Elizabeth Hamren and Blake Jorgensen Join Board of Directors
-
Alpine Immune Sciences (ALPN) Reports Key Preclinical Rationale for Davoceticept (ALPN-202)
-
Legend Biotech (LEGN) Announces Appointment of Global Head of Research and Early Development
-
Nuvalent (NUVL) Appoints Anna Protopapas as Chair of Board of Directors
-
Stanford Children's Health Launches New Center for Pediatric IBD and Celiac Disease With $70 Million Donation
-
Krystal Biotech (KRYS) Reports Publication of Phase 1 and 2 Clinical Trial of Beremagene Geperpavec
-
Midwest Holding Inc. (MDWT) Appoints Eric N. Berg as CFO
-
GitLab Inc (GTLB) Announces Resignation of David Hornik From Board
-
Vera Therapeutics Inc. (VERA) Reports Q4 Results
-
Unity Software Inc. (U) Appoints Michelle K. Lee to Board of Directors
-
United States Mint Begins Shipping American Women Quarters Program Coins Honoring Dr. Sally Ride
-
Jasper Therapeutics (JSPR) Announces Management Changes to Strengthen Leadership Team
-
Athira Pharma Inc. (ATHA) Appoints Michael A. Panzara to its Board
-
C4 Therapeutics Inc. (CCCC) Appoints Utpal Koppikar to its Board
-
The Princeton Review's 2022 College Hopes & Worries Survey Reports on 14,100 College Applicants' & Parents of Applicants' "Dream" Schools, Admission Concerns, College Perspectives, a
-
Prelude Therapeutics Inc. (PRLD) Reports FY 21 Results
-
PTC (PTC) Appoints Amar Hanspal to its Board
-
David Hall, Founder of Velodyne Lidar (VLDR), Submits Business Proposal to Remove Chairman Michael Dee for Cause
-
First Republic Bank (FRC) Board of Directors Appoints Mike Roffler as Chief Executive Officer
-
MaxCyte, Inc. (MXCT) Appoints Cenk Sumen as Chief Scientific Officer
-
Geovax Labs Inc. (GOVX) Reports 2021 Year End Results, Provides Corporate Update
-
Prelude Therapeutics Inc. (PRLD) Appoints Joins Prelude as CMO
-
CBRE Group (CBRE) Appoints Susan Meaney to its Board
-
TG Therapeutics (TGTX) Announces Data Presentations from the ULTIMATE I & II Phase 3 Trials of Ublituximab in Multiple Sclerosis to be Presented at the American Academy of Neurology Annual Meeting
-
Stanford Children's Health and John Muir Health Extend Their Long-Standing Operating Agreement for Another 10 Years
-
Hillstream BioPharma (HILS) Highlights Ferroptosis, the Non-Genetic Novel, Emerging Mechanism of Action, Targeting Drug Resistant and Devastating Cancers
-
Ping Identity (PING) Appoints Anil Arora and Vikram Verma to its Board
-
Clover Health Investments (CLOV) Appoints Conrad Wai as CTO
-
Adamis Pharmaceuticals (ADMP) Says Clinical Study Assessing Tempol for the Treatment of COVID-19 Surpasses Enrollment Expectations
-
Fang Holdings (SFUN) Announces Changes In Board Of Directors And Management
-
China Index Holdings (CIH) Announces Appointment of New Chairman of the Board and CFO

